List of Tables
    Table 1. Hematological Cancers Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Hematological Cancers Market Trends
    Table 3. Hematological Cancers Market Drivers
    Table 4. Hematological Cancers Market Challenges
    Table 5. Hematological Cancers Market Restraints
    Table 6. Global Hematological Cancers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Hematological Cancers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Hematological Cancers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Hematological Cancers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Hematological Cancers Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Hematological Cancers Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Hematological Cancers Revenue Share by Player, 2017-2022
    Table 13. Global Hematological Cancers Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Hematological Cancers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematological Cancers as of 2021)
    Table 15. Top Players of Hematological Cancers in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Hematological Cancers Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Hematological Cancers Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Hematological Cancers Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Hematological Cancers Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Hematological Cancers Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Hematological Cancers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Hematological Cancers Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Hematological Cancers Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Hematological Cancers Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Hematological Cancers Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Karyopharm Therapeutics Company Details
    Table 31. Karyopharm Therapeutics Business Overview
    Table 32. Karyopharm Therapeutics Hematological Cancers Product
    Table 33. Karyopharm Therapeutics Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 34. Karyopharm Therapeutics Recent Development
    Table 35. Johnson & Johnson Company Details
    Table 36. Johnson & Johnson Business Overview
    Table 37. Johnson & Johnson Hematological Cancers Product
    Table 38. Johnson & Johnson Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 39. Johnson & Johnson Recent Development
    Table 40. Roche Diagnostics A/S Company Details
    Table 41. Roche Diagnostics A/S Business Overview
    Table 42. Roche Diagnostics A/S Hematological Cancers Product
    Table 43. Roche Diagnostics A/S Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 44. Roche Diagnostics A/S Recent Development
    Table 45. AbbVie Company Details
    Table 46. AbbVie Business Overview
    Table 47. AbbVie Hematological Cancers Product
    Table 48. AbbVie Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 49. AbbVie Recent Development
    Table 50. Novartis Company Details
    Table 51. Novartis Business Overview
    Table 52. Novartis Hematological Cancers Product
    Table 53. Novartis Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 54. Novartis Recent Development
    Table 55. Kite Pharma Company Details
    Table 56. Kite Pharma Business Overview
    Table 57. Kite Pharma Hematological Cancers Product
    Table 58. Kite Pharma Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 59. Kite Pharma Recent Development
    Table 60. Celgene Corporation Company Details
    Table 61. Celgene Corporation Business Overview
    Table 62. Celgene Corporation Hematological Cancers Product
    Table 63. Celgene Corporation Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 64. Celgene Corporation Recent Development
    Table 65. Abbott Laboratories Company Details
    Table 66. Abbott Laboratories Business Overview
    Table 67. Abbott Laboratories Hematological Cancers Product
    Table 68. Abbott Laboratories Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 69. Abbott Laboratories Recent Development
    Table 70. Beckman Coulter Company Details
    Table 71. Beckman Coulter Business Overview
    Table 72. Beckman Coulter Hematological Cancers Product
    Table 73. Beckman Coulter Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 74. Beckman Coulter Recent Development
    Table 75. HemoCue AB Company Details
    Table 76. HemoCue AB Business Overview
    Table 77. HemoCue AB Hematological Cancers Product
    Table 78. HemoCue AB Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 79. HemoCue AB Recent Development
    Table 80. C. R. Bard Company Details
    Table 81. C. R. Bard Business Overview
    Table 82. C. R. Bard Hematological Cancers Product
    Table 83. C. R. Bard Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 84. C. R. Bard Recent Development
    Table 85. Siemens AG Company Details
    Table 86. Siemens AG Business Overview
    Table 87. Siemens AG Hematological Cancers Product
    Table 88. Siemens AG Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 89. Siemens AG Recent Development
    Table 90. Sysmex Company Details
    Table 91. Sysmex Business Overview
    Table 92. Sysmex Hematological Cancers Product
    Table 93. Sysmex Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 94. Sysmex Recent Development
    Table 95. Mindray Medical International Limited Company Details
    Table 96. Mindray Medical International Limited Business Overview
    Table 97. Mindray Medical International Limited Hematological Cancers Product
    Table 98. Mindray Medical International Limited Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 99. Mindray Medical International Limited Recent Development
    Table 100. Bio-Rad Laboratories Company Details
    Table 101. Bio-Rad Laboratories Business Overview
    Table 102. Bio-Rad Laboratories Hematological Cancers Product
    Table 103. Bio-Rad Laboratories Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 104. Bio-Rad Laboratories Recent Development
    Table 105. The Medicine Company Company Details
    Table 106. The Medicine Company Business Overview
    Table 107. The Medicine Company Hematological Cancers Product
    Table 108. The Medicine Company Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 109. The Medicine Company Recent Development
    Table 110. Pharmacyclics Company Details
    Table 111. Pharmacyclics Business Overview
    Table 112. Pharmacyclics Hematological Cancers Product
    Table 113. Pharmacyclics Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 114. Pharmacyclics Recent Development
    Table 115. Horiba Company Details
    Table 116. Horiba Business Overview
    Table 117. Horiba Hematological Cancers Product
    Table 118. Horiba Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 119. Horiba Recent Development
    Table 120. DiagnoCure Inc. Company Details
    Table 121. DiagnoCure Inc. Business Overview
    Table 122. DiagnoCure Inc. Hematological Cancers Product
    Table 123. DiagnoCure Inc. Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 124. DiagnoCure Inc. Recent Development
    Table 125. Astellas Pharma US Company Details
    Table 126. Astellas Pharma US Business Overview
    Table 127. Astellas Pharma US Hematological Cancers Product
    Table 128. Astellas Pharma US Revenue in Hematological Cancers Business (2017-2022) & (US$ Million)
    Table 129. Astellas Pharma US Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hematological Cancers Product Picture
    Figure 2. Global Hematological Cancers Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Hematological Cancers Market Size 2017-2028 (US$ Million)
    Figure 4. United States Hematological Cancers Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Hematological Cancers Market Size 2017-2028 (US$ Million)
    Figure 6. United States Hematological Cancers Market Share in Global 2017-2028
    Figure 7. Hematological Cancers Report Years Considered
    Figure 8. Product Picture of Pharmacological Therapies
    Figure 9. Product Picture of Stem Cell Transplantation
    Figure 10. Product Picture of Surgery and Radiation Therapy
    Figure 11. Product Picture of Anemia Treatment
    Figure 12. Product Picture of Thrombosis Treatment
    Figure 13. Product Picture of Neutopenia Treatment
    Figure 14. Product Picture of Symptomatic treatment
    Figure 15. Global Hematological Cancers Market Share by Type in 2022 & 2028
    Figure 16. Global Hematological Cancers Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. Global Hematological Cancers Market Share by Type (2017-2028)
    Figure 18. United States Hematological Cancers Market Share by Type in 2022 & 2028
    Figure 19. United States Hematological Cancers Market Size by Type (2017-2028) & (US$ Million)
    Figure 20. United States Hematological Cancers Market Share by Type (2017-2028)
    Figure 21. Product Picture of Epidemiology
    Figure 22. Product Picture of Pathophysiology of Leukemic Stem Cells
    Figure 23. Product Picture of Kidney Diseases
    Figure 24. Product Picture of Genetic Diseases
    Figure 25. Product Picture of Other Diseases
    Figure 26. Global Hematological Cancers Market Share by Application in 2022 & 2028
    Figure 27. Global Hematological Cancers Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. Global Hematological Cancers Market Share by Application (2017-2028)
    Figure 29. United States Hematological Cancers Market Share by Application in 2022 & 2028
    Figure 30. United States Hematological Cancers Market Size by Application (2017-2028) & (US$ Million)
    Figure 31. United States Hematological Cancers Market Share by Application (2017-2028)
    Figure 32. North America Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. U.S. Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Canada Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Europe Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. Germany Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. France Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. U.K. Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Italy Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Russia Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Asia-Pacific Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 42. China Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Japan Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. South Korea Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. India Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Australia Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. China Taiwan Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Indonesia Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Thailand Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Malaysia Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Latin America Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Mexico Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Brazil Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Argentina Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Middle East & Africa Hematological Cancers Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 56. Turkey Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. UAE Hematological Cancers Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Karyopharm Therapeutics Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 60. Johnson & Johnson Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 61. Roche Diagnostics A/S Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 62. AbbVie Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 63. Novartis Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 64. Kite Pharma Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 65. Celgene Corporation Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 66. Abbott Laboratories Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 67. Beckman Coulter Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 68. HemoCue AB Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 69. C. R. Bard Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 70. Siemens AG Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 71. Sysmex Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 72. Mindray Medical International Limited Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 73. Bio-Rad Laboratories Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 74. The Medicine Company Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 75. Pharmacyclics Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 76. Horiba Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 77. DiagnoCure Inc. Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 78. Astellas Pharma US Revenue Growth Rate in Hematological Cancers Business (2017-2022)
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed